NEW YORK (GenomeWeb News) – Illumina reported after the close of the market on Tuesday that revenues in its fourth quarter increased 25 percent year over year, including a 21 percent bump in product revenues.

The San Diego-based company said that for the last three months of 2013, it took in $387.3 million in total revenues, up from $309.3 million in the year-ago period and besting the average analyst estimate of $382.1 million.

The results were in line with what Illumina had pre-announced earlier this month.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A Harvard Business Review study found four major patterns of gender biases and added that black and Latina scientists further had to navigate racial stereotypes.

In PLOS this week: variant linked to canine cleft lip, new compression tool, and more.

GNC will start using DNA testing to authentic the presence of plants included in its labels, following an agreement with the New York Attorney General.

Fareed Zakaria writes that instead of focusing solely on STEM-related courses, students would do well to pursue the liberal arts if they want to be technology innovators.

Apr
15
Sponsored by
WaferGen

This live online seminar will highlight recent trends in applying next-generation sequencing in the clinical setting, with a particular focus on oncology and rare disease.